AbbVie wins second AndroGel liability reversal

A U.S. judge overturned a $140.1 million verdict against AbbVie in a lawsuit by a man who claimed the drugmaker misrepresented the risks of its testosterone replacement drug AndroGel.

Source: PharmaManufacturing.com - July 9, 2018 Category: Pharmaceuticals Source Type: news